Sigal Kalmanson Cusnir
Company: Starget Pharma
Job title: CEO
Seminars:
Panel Discussion: Phase 0 for Radiopharmaceuticals: Benefits & Risks 1:45 pm
Uncovering the rationale behind conducting these preliminary studies Exploring the pharmacokinetic and pharmacodynamic data it can provide Considerations for initiating a phase 0 trialRead more
day: Day 2 C&S Track Pm